Literature DB >> 21964035

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.

Teemu Kallonen1, Kirsi Gröndahl-Yli-Hannuksela, Annika Elomaa, Anna Lutyńska, Norman K Fry, Jussi Mertsola, Qiushui He.   

Abstract

Resurgence of pertussis has been observed in many countries with high vaccination coverage and clonal expansion of certain Bordetella pertussis strains has been associated with recent epidemics in Europe. It is known that vaccinations have selected strains which are different from those used for vaccine production. However, little is known about the differences in genomic content of strains circulating before the vaccination was introduced. In this study, we compared the genomes of 39 vaccine strains and old clinical isolates (isolated 1941-1984) collected from Finland (n = 5), Poland (n = 14), Serbia (n = 10) and the UK (n = 10). The analysis included genotyping, pulsed-field gel electrophoresis (PFGE) and comparative genomic hybridisation (CGH). Compared to the strain Tohama I, the European isolates analyzed have lost three major regions of difference (RD3, 5 and 29). However, difference in frequency of the absent RDs 3 (BP0910A-BP0934), 5 (BP1135-BP1141) or 29 (BP1225) was observed among isolates from the four countries. Of the isolates with absent RD5, half had also a duplicated region in the genome. All four RDs (RD22 (BB0535-BB0541), 23 (BB0916-BB0921), 24 (BB1140-BB1158) and 26 (BB4880-BB4888)) absent in Tohama I were present in majority of the tested isolates. Results obtained from PFGE analysis correlated well with those of CGH. Recently a novel pertussis toxin promoter allele (ptxP3) was described. Isolates with ptxP3 have replaced resident ptxP1 isolates in the countries where this was investigated. When the recent isolates, collected in 2000-2004, selected from the four countries were examined, the ptxP3 allele was found in all countries except Poland. Our result indicates that at least three clusters of B. pertussis circulated in Europe in pre- and early vaccine era and their genomes were distinct from that of the reference strain Tohama I. Although progressive gene loss occurs in B. pertussis population with time, difference in frequency of the lost genes were observed among isolates from the four countries. The observed differences in genomic content might be vaccine-driven.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964035     DOI: 10.1016/j.meegid.2011.09.012

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  20 in total

Review 1.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

2.  The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement.

Authors:  Michael R Weigand; Yanhui Peng; Vladimir Loparev; Dhwani Batra; Katherine E Bowden; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Marsenia H Mathis; Andrea M Pruitt; Lori Rowe; Mili Sheth; M Lucia Tondella; Margaret M Williams
Journal:  J Bacteriol       Date:  2017-03-28       Impact factor: 3.490

3.  Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Authors:  Fatemah Sadeghpour Heravi; Vajihe Sadat Nikbin; Masomeh Nakhost Lotfi; Pouran Badiri; Nazanin Jannesar Ahmadi; Seyed Mohsen Zahraei; Fereshteh Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-09       Impact factor: 3.267

4.  Hyperbiofilm Formation by Bordetella pertussis Strains Correlates with Enhanced Virulence Traits.

Authors:  Natalia Cattelan; Jamie Jennings-Gee; Purnima Dubey; Osvaldo M Yantorno; Rajendar Deora
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

Review 5.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

Authors:  L C Pawloski; A M Queenan; P K Cassiday; A S Lynch; M J Harrison; W Shang; M M Williams; K E Bowden; B Burgos-Rivera; X Qin; N Messonnier; M L Tondella
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

Review 7.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

8.  Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.

Authors:  Michael R Weigand; Lucia C Pawloski; Yanhui Peng; Hong Ju; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Marina DuVall; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Vladimir N Loparev; Marsenia H Mathis; Lori A Rowe; Mili Sheth; Margaret M Williams; M Lucia Tondella
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

9.  Fundamental differences in physiology of Bordetella pertussis dependent on the two-component system Bvg revealed by gene essentiality studies.

Authors:  Thomas Belcher; Iain MacArthur; Jerry D King; Gemma C Langridge; Matthew Mayho; Julian Parkhill; Andrew Preston
Journal:  Microb Genom       Date:  2020-12-09

10.  Small mutations in Bordetella pertussis are associated with selective sweeps.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Frits R Mooi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.